Company: CERO
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001213900-25-073849
Chunk: 5

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-11
Form: S-3
Chunk 5
---
 dated as of June 4, 2023, as amended by Amendment No. 1, dated February
5, 2024 and Amendment No. 2, dated February 13, 2024, by and between PBAX, Merger Sub and Legacy CERo.

“Bylaws”
refers to the Second Amended and Restated Bylaws of CERo.

“CERo”
refers to CERo Therapeutics Holdings, Inc.

“Charter”
refers to CERo’s Second Amended and Restated Certificate of Incorporation, as filed with the Secretary of the State of Delaware
on February 14, 2024.

“Closing”
refers to the closing of the Business Combination.

“Common Stock”
refers to the common stock, par value $0.0001 per share, of CERo.

“DGCL”
refers to the Delaware General Corporation Law, as may be amended from time to time.

“Exchange Act”
refers to the Securities Exchange Act of 1934, as amended.

“FDA”
refers to the U.S. Food and Drug Administration, or any successor agency thereto.

“Fourth PIPE Financing”
refers to the private placement pursuant to which we issued and sold, and the PIPE Investors purchased, shares of Series D Preferred Stock,
on the terms and conditions set forth in the Fourth Securities Purchase Agreement.

“Fourth PIPE Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of April 22, 2025, by and between CERo and certain PIPE
Investors.

“Fourth Securities Purchase Agreement” refers to the Securities Purchase Agreement, dated as of April 21, 2025, as amended as of June 25, 2025,
by and among CERo and certain PIPE Investors, pursuant to which CERo agreed to issue and sell up to 10,000 shares of Series D Preferred
Stock.

“Keystone”
refers to Keystone Capital Partners, LLC.

“Legacy CERo”
refers to CERo Therapeutics, Inc.

“Merger Sub”
refers to PBCE Merger Sub, Inc., a Delaware corporation.

“Nasdaq”
refers to the Nasdaq Stock Market LLC.

“PIPE Investors”
refer to the investors in the Fourth PIPE Financing.

“Preferred Shares”
refer to the shares of Series D Preferred Stock issued in the Fourth PIPE Financing.

“SEC”
refers to the U.S. Securities and Exchange Commission.

“